Abstract
The biological half-life of manganese and some factors influencing it have been studied in man. The disappearance of manganese from the body in normal subjects is described by a curve having two exponential components. An average of 70% of the injected material was eliminated by the “slow” pathway. The half-time characterizing this component showed a small variation in normal subjects and had an average value of 39 days. The half-time for the “fast” component also showed a small variation and had an average value of 4 days.
In a normal subject presumed to have a low manganese intake due to a voluntary low caloric intake, the percentage eliminated by the slow pathway increased to 84% and the half-time characterizing the pathway increased to 90 days. The half-time of the “fast” component was the same as for the normal group. 2 months after initiation of the study in this subject, a large “flushing” dose of manganese markedly increased the elimination rate which was described by a single exponential curve.
A mildly iron-deficient subject showed a marked decrease in the percentage of manganese eliminated by the “slow” pathway accompanied by a less dramatic decrease in the half-time characterizing this pathway. Oral iron therapy, which corrected the mild anemia, caused a decrease in the elimination rate and the altered curve was described by a single exponential component.
Preloading two subjects with manganese resulted in a great decrease in the fraction eliminated by the “slow” pathway with less effect on the half-time. The subject with the largest preloading dose showed no “slow” component at all.
Observations on the red cells of some of these subjects showed that a small but definite fraction was incorporated into the erythrocytes.
In the mildly iron-deficient subject, our observations suggest an interrelationship between manganese and iron metabolism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altstatt L. B., Pollack S., Feldman M. H., Reba R. C., Crosby W. H. Liver manganese in hemochromatosis. Proc Soc Exp Biol Med. 1967 Feb;124(2):353–355. doi: 10.3181/00379727-124-31741. [DOI] [PubMed] [Google Scholar]
- BORG D. C., COTZIAS G. C. Incorporation of manganese into erythrocytes as evidence for a manganese porphyrin in man. Nature. 1958 Dec 13;182(4650):1677–1678. doi: 10.1038/1821677a0. [DOI] [PubMed] [Google Scholar]
- BORG D. C., COTZIAS G. C. Manganese metabolism in man: rapid exchange of MN56 with tissue as demonstrated by blood clearance and liver uptake. J Clin Invest. 1958 Sep;37(9):1269–1278. doi: 10.1172/JCI103714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Britton A. A., Cotzias G. C. Dependence of manganese turnover on intake. Am J Physiol. 1966 Jul;211(1):203–206. doi: 10.1152/ajplegacy.1966.211.1.203. [DOI] [PubMed] [Google Scholar]
- COTZIAS G. C., GREENOUGH J. J. The high specificity of the manganese pathway through the body. J Clin Invest. 1958 Sep;37(9):1298–1305. doi: 10.1172/JCI103718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- POLLACK S., GEORGE J. N., REBA R. C., KAUFMAN R. M., CROSBY W. H. THE ABSORPTION OF NONFERROUS METALS IN IRON DEFICIENCY. J Clin Invest. 1965 Sep;44:1470–1473. doi: 10.1172/JCI105253. [DOI] [PMC free article] [PubMed] [Google Scholar]